Overview

Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days

Status:
Completed

Trial end date:
2012-03-01

Target enrollment:

Participant gender:

Summary

The present prospective study was designed to compare the effects of administering a daily dose of gonadotrophin releasing hormone (GnRH) antagonist vs. an alternate-day dosage of GnRH agonist on ovarian response and in vitro fertilization (IVF) outcome in patients stimulated with recombinant follicle-stimulating hormone (FSH) and human chorionic gonadotrophin (hCG) microdose.

Phase:

N/A

Details

Lead Sponsor:

Fertility - Assisted Fertilization Center

Treatments:

Cetrorelix
Deslorelin
Follicle Stimulating Hormone
Triptorelin Pamoate